Upgrade to SI Premium - Free Trial

Iovanace Biotherapeutics (IOVA) PT Raised to $13 at Barclays

August 7, 2026 4:54 AM
Barclays analyst Peter Lawson raised ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change